Clinical trial
Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of…
NCT00225264 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00225264 |
|---|---|
| Title | Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease. |
| Official title | A Double-Blind, Randomized, Comparator-Controlled Study in Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl Versus Glimepiride on the Rate of Progression of Atherosclerotic Disease as Measured by Carotid Intima-Media Thickness |
| Acronym | CHICAGO |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Pioglitazone, Glimepiride |
| Enrollment | 458 |
| Start date | Oct 1, 2003 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Sep 23, 2005 |
| Last update posted | Feb 28, 2012 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: